Skip to the page

Data / Drug companies / InterMed Laboratories Private Limited

InterMed Laboratories Private Limited: 10 products in the FDA NDC directory, labeler code 71811

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

InterMed Laboratories Private Limited (labeler code 71811) lists 10 products in the FDA National Drug Code Directory, covering 3 finished drugs by generic name. By type: 10 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 6, 2025.

The request: Watch InterMed Laboratories Private Limited (FDA labeler code 71811): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
71811
Products in commercial distribution
10
Packages
13
Finished drugs by generic name
3
Prescription products
0
Over the counter products
10
Flagged as original packager
10 of 10 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
September 24, 2019
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs770%
Other unapproved drugs330%

Products by type

TypeProductsShare
Over the counter drugs10100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Lidocaine7216
Menthol2263
Lidocaine and menthol117

Dosage forms

Dosage formProductsShare
Patch10100%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Maximum Strength 4% Lidocaine Patch Good Neighbor Pharmacy71811-010PatchOver the counter monograph drugsNovember 6, 2025
Maximum Strength 4% Lidocaine Patch HealthA2Z71811-009PatchOver the counter monograph drugsNovember 6, 2025
Maximum Strength 4% Lidocaine Patch Good Neighbor Pharmacy71811-008PatchOver the counter monograph drugsNovember 6, 2025
Maximum Strength 4% Lidocaine Patch Leader71811-007PatchOver the counter monograph drugsNovember 6, 2025
Cold Hot Medicated Patch 5% Menthol71811-006PatchOver the counter monograph drugsApril 29, 2025
Cold Hot Medicated Patch 5% Menthol71811-005PatchOver the counter monograph drugsApril 29, 2025
Maximum Strength 4% Lidocaine Patch71811-004PatchOver the counter monograph drugsApril 29, 2025
Pain Relieving Lidocaine Patch71811-003PatchOther unapproved drugsSeptember 17, 2020
Hot and Cold Lidocaine with Menthol Patch Pain Relief71811-002PatchOther unapproved drugsNovember 22, 2019
Maximum strength Lidocaine Patch71811-001PatchOther unapproved drugsSeptember 24, 2019

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.